Nurix Therapeutics, Inc. (NRIX)
15.95
-9.87
(-38.23%)
USD |
NASDAQ |
Nov 04, 16:00
15.97
+0.02
(+0.13%)
After-Hours: 07:29
Nurix Therapeutics Price : 15.95 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2026 | 17.16 | 17.28 | 14.78 | 15.95 | 19.56M |
| Nov 03, 2026 | 25.72 | 26.55 | 25.63 | 25.82 | 4.387M |
| Nov 02, 2026 | 26.75 | 26.96 | 25.53 | 25.70 | 2.349M |
| Oct 30, 2026 | 26.90 | 26.92 | 25.97 | 26.80 | 2.311M |
| Oct 29, 2026 | 27.46 | 27.99 | 26.68 | 27.12 | 2.375M |
| Oct 28, 2026 | 26.26 | 27.28 | 25.45 | 27.26 | 1.958M |
| Oct 27, 2026 | 25.52 | 27.05 | 25.13 | 26.70 | 2.563M |
| Oct 26, 2026 | 25.35 | 25.82 | 25.03 | 25.55 | 2.337M |
| Oct 23, 2026 | 25.22 | 25.49 | 24.78 | 25.34 | 1.910M |
| Oct 22, 2026 | 25.86 | 26.22 | 25.18 | 25.51 | 1.934M |
| Oct 21, 2026 | 26.00 | 26.31 | 25.80 | 26.02 | 2.928M |
| Oct 20, 2026 | 24.92 | 26.34 | 24.71 | 26.10 | 3.980M |
| Oct 19, 2026 | 24.57 | 25.29 | 24.38 | 24.93 | 3.064M |
| Oct 16, 2026 | 24.89 | 25.36 | 24.26 | 24.42 | 4.318M |
| Oct 15, 2026 | 23.67 | 25.14 | 23.61 | 24.95 | 3.754M |
| Oct 14, 2026 | 22.01 | 24.01 | 21.40 | 23.67 | 3.821M |
| Oct 13, 2026 | 22.16 | 23.24 | 21.75 | 22.13 | 4.681M |
| Oct 12, 2026 | 22.27 | 22.58 | 22.02 | 22.16 | 2.853M |
| Oct 09, 2026 | 22.04 | 23.23 | 21.23 | 22.35 | 1.525M |
| Oct 08, 2026 | 22.49 | 22.60 | 21.55 | 22.21 | 2.345M |
| Oct 07, 2026 | 22.43 | 23.10 | 22.18 | 22.73 | 1.632M |
| Oct 06, 2026 | 23.06 | 23.06 | 22.10 | 22.60 | 1.154M |
| Oct 05, 2026 | 22.81 | 23.31 | 22.42 | 22.88 | 1.007M |
| Oct 02, 2026 | 23.72 | 23.74 | 22.85 | 22.99 | 815509.0 |
| Oct 01, 2026 | 23.60 | 23.98 | 23.21 | 23.34 | 1.335M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 174.48 |
| ACADIA Pharmaceuticals, Inc. | 21.47 |
| Alnylam Pharmaceuticals, Inc. | 161.08 |
| Anika Therapeutics, Inc. | 20.40 |
| Savara, Inc. | 4.66 |
Price Related Metrics
| PE Ratio | 6.896 |
| PS Ratio | 2.456 |
| Price to Book Value | 1.799 |
| Price to Free Cash Flow | 4.662 |
| Earnings Yield | 14.50% |
| Market Cap | 1.742B |
| Operating PE Ratio | 5.952 |
| Normalized PE Ratio | 6.896 |